Skip to main content
. 2021 Jun 1;11(3):20458940211028017. doi: 10.1177/20458940211028017

Fig. 1.

Fig. 1

Lung 18FLT uptake was measured (phosphorylation rate k3 of 18FLT). No differences were observed between controls (n = 9), unaffected mutation carriers (UMC, n = 11) and PAH patients (n = 21) in whole lungs (a), whole lungs corrected for lung density measured with CT‐scan (b) and in the mid‐region of the lungs (c).

18FLT: 3′‐deoxy‐3′‐[18F]‐fluorothymidine; HPAH: heritable pulmonary arterial hypertension; IPAH: idiopathic pulmonary arterial hypertension.